Graphite Bio, Inc. (NASDAQ: GRPH) had its price target lowered by analysts at Royal Bank of Canada from $4.00 to $3.00.
Graphite Bio, Inc. (GRPH)
NASDAQ:AMEX Investor Relations:
alabamagraphite.com/investors-page
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
GRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRPH alerts
High impacting Graphite Bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRPH
News
- LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress [Yahoo! Finance]Yahoo! Finance
- Graphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare movers [Seeking Alpha]Seeking Alpha
- Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics [Yahoo! Finance]Yahoo! Finance
- Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsBusiness Wire
- GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHBusiness Wire
GRPH
Earnings
- 11/13/23 - Miss
GRPH
Sec Filings
- 3/22/24 - Form 8-K
- 3/19/24 - Form 8-K
- 3/15/24 - Form SEC
- GRPH's page on the SEC website